skin. Revolutionizing Collagen Filler Technology SKINCOLLA is a game-changer in aesthetic treatments. It combines 100% human-identical recombinant collagen with Hyaluronic Acid (HA), providing immediate and lasting improvements to skin texture,...
PharmAID Decision Intelligence Platform Integrates Global Leading Large Model Technology and Has connected with Deepseek R1 As a pioneer in the AI transformation of the pharmaceutical industry, Fosun Pharma recently launched its self-developed...
strategic approach and its ability to adapt and succeed in dynamic market conditions. With a vision to rank among the top 100 pharmaceutical companies globally, Grindeks continues to drive innovation, expand its reach, and strengthen its...
Verma, president of Fresenius Kabi Region U.S. and member of the executive leadership team at Fresenius Kabi AG. Since 2017, Fresenius Kabi has invested nearly $1 billion to modernize and expand its advanced U.S. pharmaceutical production and...
The safety and efficacy of KYZATREX was demonstrated in a phase 3, multi-center, open-label, six-month study in 155 hypogonadal males between 18 and 65 years of age with documented hypogonadism, as defined by a below normal serum testosterone level...
clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced the completion of the 10,000th case in the U.S. with the Match-the-Disc™ prodisc Cervical TDR System. The new Match-the-Disc prodisc Cervical TDR...
Global Business Units, Healthcare, at Jabil. Jabil is a leader in parenteral drug delivery, in support of markets like GLP-1s. This acquisition will significantly enhance Jabil’s existing Pharmaceutical Solutions offering, which includes the...
transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare, and Global Brain in this financing....
biophysical properties. We will continue exploring its therapeutic potential to benefit patients worldwide." On January 10, 2025, Harbour BioMed and Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech") entered into a global licensing...
industry. Most recently, he served as CFO at Proteome Sciences plc and Paion AG where he successfully secured more than €150mln in financing and played a pivotal role in establishing key commercial infrastructure across Europe. Earlier in this...
for the treatment of cancer and serious infectious diseases, today announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United...
is the CEO of Entrada Therapeutics and a Member of its Board of Directors. He previously served as President and CEO from 2017 to 2023. Mr. Doshi has led critical functions in biotechnology and pharmaceutical companies, including roles focused on...
and complex central nervous system disorders who have unmet medical needs. Headquartered in Switzerland and founded in 2015, NLS is led by an experienced management team with a track record of developing and commercializing product candidates. For...
the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries. The company holds the global rights to the name and trademark “Merck” internationally. The only...
fully enrolled, Phase 2, randomized, controlled study evaluating the safety, efficacy and tolerability of laru-zova in 14 male patients with XLRP caused by mutations in the RPGR gene. The study's primary endpoint is the proportion of response by...
cutaneous dose-limiting toxicity, announced that it has secured a $30 million financing to advance the development of LUT014, an innovative topically applied gel aimed at reducing EGFRi-induced rashes, a common adverse side effect of these...
progenitor cells (nCPCs), today announced a partnership for cGMP manufacturing of Secretome Therapeutic's lead asset STM-01. Under this partnership, Cellipont Bioservices will provide technology transfer, analytical method transfer, and cGMP...
This one-step press-fit solution for vial closure is offered in ready-to-use, validated formats compatible with vials with 13mm and 20 mm crowns. The new 6x8 nested tub configuration supports the West 10ml nested CZ vials as well as selected nested...
achievement of clinical validation through its Phase 2a clinical trial in psoriasis with fully proprietary oral agent AX-158. These results confirm the strong Phase 1 and preclinical data package, underscoring the potential breadth and depth of Nck...
million cases in 2023, according to the World Health Organization. Despite the expenditure of $4 billion per year on control1, malaria deaths and cases have not substantively changed over the last decade. Consequently, a safe, effective,...
